Dec 30, 2024, 08:49 | Science

Alessio Cortellini: Strength lies in collaboration

Alessio Cortellini, Consultant Medical Oncologist and Assistant Professor at UCBM, reshared a post by Elio…

Dec 29, 2024, 13:27 | Blog

Adam Lenkowsky: Celebrating the FDA approval of our new subcutaneous immunotherapy for patients with certain cancers

Adam Lenkowsky, Executive Vice President, Chief Commercialization Officer at Bristol Myers Squibb, reshared a post…

Dec 28, 2024, 15:55 | Science

Chris Boerner: The FDA approved our new subcutaneous immunotherapy treatment

Chris Boerner, Board Chair and Chief Executive Officer at Bristol Myers Squibb, posted on LinkedIn:…

Dec 28, 2024, 14:09 | Science

The new NCCN guidelines for immunotherapy-related toxicities

Elvina Almuradova, Associate Professor and Medical Oncologist Ambassador at European School of Oncology, shared a…

Dec 28, 2024, 13:49 | Insight

Timothée Olivier: What is the best 1st line immunotherapy regimen for patients with advanced/meta melanoma?

Timothée Olivier, Medical oncologist at the Oncology Division of Geneva University, shared a recent article…

Dec 27, 2024, 14:15 | Science

Classification of progressive disease based on PD patterns in patients treated with ICIs - JAMA Oncology

JAMA Oncology shared a recent article by Jonas Saal on X: "A modified classification of…

Dec 27, 2024, 14:10 | Science

Niklas Klümper: Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy

Niklas Klümper, Senior Urology Consultant at the University Medical Center Bonn, shared a recent article…

Dec 25, 2024, 18:29 | Blog

Save the Date for the Congress on Cellular and Humoral Immunotherapy in Autoimmunity (CHIA 2025)

CHIA posted on X: "Save the Date! September 18–20, 2025 Paris and Online Explore breakthroughs…

Dec 25, 2024, 14:47 | Science

Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared a recent article on…

Dec 25, 2024, 03:40 | Science

The effect of exercise in aiding cancer treatment and mitigating the treatment side-effects, suggested by Christopher Fitzmaurice

Christopher Fitzmaurice, Clinical Exercise Physiologist at University of Miami Health System, shared an article by…

Dec 24, 2024, 13:29 | Science

Francesco Schettini: Which ADC is to prioritise in HR+ and TN BC?

Francesco Schettini, Medical Oncologist at the Breast Unit of the Hospital Clinic of Barcelona and…

Dec 24, 2024, 11:40 | Blog

Joshua Brody: Practice-changing ASH24 updates on Follicular Lymphoma Immunotherapy

Joshua Brody, Director of Lymphoma Immunotherapy Program at The Icahn School of Medicine at Mount…

Dec 24, 2024, 11:31 | Science

Breakthrough of solid tumor treatment: CAR-NK immunotherapy, review by Hung Trinh

Hung Trinh, Senior Director of Business Development at OBiO Tech, shared an article by Wenkang…

Dec 24, 2024, 11:28 | Insight

Jack Huang: Strategies of Combination Immunotherapies in Cancer

Jack Huang, Chief Scientist and Founder/CEO of CSTEAM biotechnology, shared a post on LinkedIn on…

Dec 23, 2024, 15:26 | Blog

iOmx Therapeutics submitted Clinical Trial Application for IOMX-0675

iOmx Therapeutics has announced the submission of the Clinical Trial Application (CTA) for IOMX‑0675, the…

Dec 23, 2024, 15:21 | Insight

GI Innovation Dosed First Patient in Phase 1 Trial of "GI-102" Immuno-Oncology Drug

GI Innovation announced on December 23 the successful completion of the first patient dosing in…

Dec 23, 2024, 11:45 | Dialogues

Dr. Jason Luke's Journey in Immuno-Oncology Innovation

In this episode of OncoDaily, Dr. Jason J. Luke, a leading expert in Malignant Hematology…

Dec 22, 2024, 17:47 | Insight

Next-gen immunotherapy is reshaping lung cancer treatment

Therapeutic Advances in Medical Oncology shared a post on X: “Next-gen immunotherapy is reshaping lung…

Dec 22, 2024, 17:39 | Blog

Mark Cobbold: Incredible Year in Cell Therapy and Immunotherapy at AstraZeneca

Mark Cobbold, SVP of IO Discovery and Cell Therapy Oncology at AstraZeneca, shared on LinkedIn:…

Dec 22, 2024, 14:32 | Science

10 Top Translational Papers in GU Oncology suggested by Toni Choueiri

Toni Choueiri, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, shared…

Dec 22, 2024, 12:39 | Blog

Nuria Vilamajo: Books against cancer - unites reading, solidarity and science

Nuria Vilamajo, Head of Patronage at Barcelona Clinical Hospital, shared a post on LinkedIn: "Girem…

Dec 22, 2024, 10:03 | Science

María Natalia Gandur Quiroga: Checkpoint inhibitors and Fc functions - key findings in oncology immunotherapy

María Natalia Gandur Quiroga, Chief of the Division of Genitourinary Medical Oncology at the Ángel…

Dec 21, 2024, 10:09 | Dialogues

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Interview with Mikhail Groubman, By the Editor-in-Chief of OncoDaily, Gevorg Tamamyan Mikhail Groubman is the…

Dec 20, 2024, 16:03 | Blog

John Marshall: Dive into the latest advancements in pancreatic cancer on Oncology Unscripted

John Marshall, Chief, Division of Hematology and Oncology at Georgetown University Medical Center, shared a…

Dec 19, 2024, 15:19 | Science

Pashtoon Kasi: ASCO GI25 - More about the immunotherapy BOT/BAL

Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, Orange County, shared a…

Dec 19, 2024, 12:55 | Science

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and…

Dec 19, 2024, 02:54 | Blog

Bladder-Sparing Strategies for MIBC: Insights from Professor Ming Cao at ESMO Asia2024

Mediamedic shared a post on LinkedIn: "Bladder-Sparing Strategies for MIBC: Insights from Professor Ming Cao at…

Dec 18, 2024, 15:52 | Science

Merck has announced the Discontinuation of KeyVibe and KEYFORM Programs

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the…

Dec 18, 2024, 12:00 | Blog

Jean-Charles Soria: How FcγR engagement influences antibody efficacy, toxicity and pharmacokinetics

Jean- Charles Soria shared on LinkedIn: "FcγR engagement influences antibody efficacy, toxicity and pharmacokinetics: 1) Effector…

Dec 18, 2024, 11:36 | Blog

New Article on OncoDaily Medical Journal by Agop Y. Bedikian

The OncoDaily Medical Journal has published a new review article by Agop Y. Bedikian. Shushan…

Dec 18, 2024, 10:30 | Blog

Nicholas Restifo: A Breakthrough Year for T Cells

Nicholas Restifo, Co-founder and Chief Scientist at Marble Therapeutics, shared on LinkedIn: “A Breakthrough Year…

Dec 17, 2024, 19:57 | Blog

Amol Akhade: What after Immunotherapy?

Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals,…

Dec 16, 2024, 08:33 | Insight

Jarushka Naidoo: KN867 trial shows no EFS benefit for SBRT+Pembro in NSCLC

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), posted the following on X: “ESMO…

Dec 15, 2024, 08:59 | Blog

Francisco J. Esteva: The role of immunotherapy in early-stage triple-negative breast cancer

Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…

Dec 14, 2024, 13:59 | Insight

ASH: Monoclonal antibody therapy improves survival in cancer-associated hyper-inflammatory disorder

ELA026 Shows Promising Results in Phase Ib Trial for Malignancy-Associated HLH. MD Anderson Researchers Report…

Dec 12, 2024, 13:36 | Blog

Stephen Liu: Join the IASLC Immunotherapy for Lung Cancer Regional Series

Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post on LinkedIn: "Join…

Dec 11, 2024, 14:33 | Blog

Aakash Desai: The next frontier in immunotherapy Oral immune checkpoint inhibitors

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared a post on LinkedIn:…

Dec 11, 2024, 13:04 | Insight

Gustavo Viani: How to approach GEJ adenocarcinoma

Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao Paulo,…

Dec 9, 2024, 18:22 | Blog

Alessio Cortellini: 10th Symposium on Advances in Cancer Immunology and Immunotherapy

Alessio Cortellini, Assistant Professor at Campus Bio-Medico University of Rome, shared a post on X:…

Dec 9, 2024, 14:46 | Blog

Andrea Boutros: Impact of Novel Systemic Immunotherapy and Targeted Therapies on Fertility in Melanoma Patients

Andrea Boutros, Medical Doctor and Oncology Resident at San Martino Polyclinic Hospital, shared a post…

Dec 9, 2024, 13:23 | Insight

Hind Rafei: Brief Updates on CAR-Natural Killer Cell Therapy for Cancer

Hind Rafei, Assistant Professor in the Department of Stem Cell Transplantation and Cellular Therapy at…

Dec 8, 2024, 15:40 | Insight

LATAM Course II: Immunotherapy in Lung Cancer by IASLC

LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19th,…

Dec 8, 2024, 10:44 | Blog

2025's Most Promising Cancer Therapies Explained by Francisco J. Esteva

Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…

Dec 7, 2024, 16:57 | Blog

Jemma Arakelyan: Discussing dMMR colorectal cancers at Asian Congress

Jemma Arakelyan, Medical Oncologist and the Chief Executive Officer of The Institute of Cancer and…

Dec 7, 2024, 10:47 | Blog

Rational CAR design for augmented T cell function - Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer shared the following on X: “New JITC article: Integrating binding…

Dec 6, 2024, 10:29 | Blog

Mohamad Mohty: Reflections before the start of ASH24

Mohamad Mohty, Professor of Hematology at Sorbonne University and head of the Clinical Hematology and…

Dec 5, 2024, 14:30 | Blog

LATAM Course II: Immunotherapy in Lung Cancer by IASLC

LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19,…

Dec 5, 2024, 09:37 | Blog

Tremelimumab and durvalumab for MSI-H gastric cancer

Yakup Ergün, Medical Oncologist at Bower Hospital, shared a paper by Raimondi et al. on…

Dec 4, 2024, 17:52 | Blog

Anirban Maitra: Amazing combo ICI results but an unfair comparator arm

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…

Dec 1, 2024, 22:10 | Blog

Ibrahim Halil Sahin: Advances in Colorectal Cancer Precision Medicine

Ibrahim Halil Sahin, Assistant Professor at UPMC Hillman Cancer Center, retweeted a post by Cancers…

Dec 1, 2024, 20:31 | Insight

Christian P. Pallasch: Pallasch lab's latest study on Pentose Phosphate Pathway Inhibition published in Cell Reports Medicine

Christian P. Pallasch, Professor at University Hospital of Cologne, shared on LinkedIn: “Thrilled to announce…

Nov 30, 2024, 23:26 | Blog

Enrique Grande: SITC Guideline on Immunotherapy for Urothelial Cancer

Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, shared a post…

Nov 30, 2024, 22:15 | Blog

Giampaolo Bianchini: Cast your vote in the ASCO 2025 election

Giampaolo Bianchini, Head of the Translational and Immunotherapy Research Group at the San Raffaele Scientific…

Nov 30, 2024, 01:12 | Insight

Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer, Summarized by Paolo Cotzia

Paolo Cotzia, Medical Director of Molecular Pathology and Head of Molecular Excellence at Sonic Healthcare…

Nov 28, 2024, 12:35 | Blog

David R. Spigel: Putting the Pieces Together - Looking at Lung Cancer

David R. Spigel, Chief Scientific Officer at Sarah Cannon Research Institute, shared a post on…

Nov 27, 2024, 16:03 | Blog

María Natalia Gandur Quiroga: Case Discussion - Treatment Options for Metastatic pRCC

María Natalia Gandur Quiroga, Coordinator in charge of the Urological Clinical Service of the Angel…

Nov 27, 2024, 11:39 | Immune Oncology

Immunotherapy for Bladder Cancer: Types, Success Rate, Side Effects & More

Immunotherapy has become a transformative approach in treating bladder cancer, utilizing the immune system to…

Nov 26, 2024, 14:09 | Insight

LCRF and IASLC Announced First Team Science Award Grant for Lung Cancer Research

The Lung Cancer Research Foundation (LCRF) and the International Association for the Study of Lung…

Nov 25, 2024, 13:47 | Blog

Herbert Loong Highlights Advances in Lung Cancer Therapies and Insights on HCC at IOHK2024

Immuno-Oncology Hong Kong 2024 Conference was held from November 23-24, 2024. It was hosted by…

Nov 25, 2024, 12:46 | Blog

ESMOBreast25: Join global experts to explore cutting-edge research in breast cancer care

ESMO shared on LinkedIn: "ESMOBreast25: Join global experts to explore cutting-edge research in breast cancer care…

Nov 24, 2024, 15:45 | Blog

Shivani Modi: The Goat of GI oncology, Ilson David

Shivani Modi, Resident at Jefferson Health – Einstein, shared a post on X: "Euphoria to…

Nov 24, 2024, 13:47 | Insight

Beau Bosko Toskich: A multidisciplinary review of combination Y90 and Immunotherapy for HCC

Beau Bosko Toskich, Interventional Radiologist at Mayo Clinic, shared a post on X: “A multidisciplinary…

Nov 24, 2024, 07:43 | Dialogues

Prof. Yelena Janjigian's Inspiring Path in GI Oncology | OncoDaily

In this episode of OncoDaily, Prof. Yelena Janjigian, a renowned GI oncology expert from Weill…

Nov 22, 2024, 17:22 | Insight

Chiara Corti: Estrogen Signaling in Early-Stage Breast Cancer

Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “I am…

Nov 20, 2024, 15:19 | Insight

Eric Lim: Immunotherapy - before, after or both?

Eric Lim, Professor of Thoracic Surgery at Royal Brompton Hospital, shared his recent article on…

Nov 19, 2024, 20:55 | Blog

Rawia Mohamed: Updates and Insights on MMR in Colorectal Cancer

Rawia Mohamed, Head of the Anatomical Pathology Department at Burjeel Medical City, shared a post…

Nov 19, 2024, 20:50 | Blog

What a Ph.D. student needs to know about Cancer Immunology and Immunotherapy - CCIT-DK

CCIT-DK - National Center for Cancer Immune Therapy of Denmark shared a post on LinkedIn: “What…

Nov 19, 2024, 20:48 | Insight

Jun Gong: ctDNA-guided adjuvant immunotherapy in stage III MSI-H dMMR colon cancer

Jun Gong, Medical Oncologist and Researcher at Cedars-Sinai Medical Center, shared a post on X…

Nov 19, 2024, 20:44 | Blog

Dhan Chand: Expanding treatment options through innovative iNKT cell therapy combinations

Dhan Chand, Vice President of Research at Agenus, shared a post on LinkedIn: "Novel cell…

Nov 19, 2024, 14:54 | Insight

Sarcopenia and inflammation predict poorer outcomes in Cancer Immunotherapy

George Vlachogiannis, Executive Editor of Cancer Control at Sage Publishing, shared an article by Enes…

Nov 19, 2024, 13:43 | Insight

Highlights from New York Lung Cancers Symposium 2024 by Stephen V Liu

The New York Lung Cancers Symposium 24 (NYLung24) took place on 16th of November 2024,…

Nov 18, 2024, 14:07 | Drugs

IDRx Announces Updated Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial of IDRX-42

IDRx Announces Updated Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial of IDRX-42…

Nov 17, 2024, 12:17 | Insight

Jarushka Naidoo: Do we need PCI in SCLC in the IO era?

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X about…

Nov 17, 2024, 07:58 | Blog

523 Gene test identifies 67% of patients for Targeted Therapy or Immunotherapy

Bernard A. Fox, Adjunct Professor in the Department of Molecular Microbiology and Immunology at the…

Nov 16, 2024, 15:52 | Insight

Lucjan Wyrwicz: Immunotherapy in cancer is a story of success

Lucjan Wyrwicz, Head of Department, Dept. of Oncology and Radiotherapy at Maria Skłodowska-Curie Memorial Cancer…

Nov 16, 2024, 11:50 | Blog

Sarah Louden: The Power of Comprehensive Genomic Profiling

Sarah Louden, Founder and CEO of Total Health, shared a post on LinkedIn: “To fully disclose, I worked…

Nov 15, 2024, 21:26 | Blog

Johanna Joyce: An inspiring end to our Tumor Immunology and Immunotherapy

Johanna Joyce, Professor at the University of Lausanne and Full Member of the international Ludwig…

Nov 15, 2024, 15:59 | Blog

Shushan Hovsepyan: Can we change the game for sarcoma patients with immunotherapy?

Shushan Hovsepyan shared on LinkedIn: "Can we change the game for sarcoma patients with immunotherapy? Two…

Nov 14, 2024, 17:48 | Blog

Marco Donia: Pleased to be Co-chairing with Timothée Olivier in an educational session at ESMOImmuno24

Marco Donia, Senior Consultant, Clinician-Scientist and Junior Research Group Leader (TIL group) at University of…

Nov 14, 2024, 16:27 | Insight

Jiasen He: Immunotherapy-related neurotoxicity in children with cancer

Jiasen He, Clinical Fellow at the MD Anderson Cancer Center, shared a post on X:…

Nov 14, 2024, 14:40 | Dialogues

Advances in Head and Neck Cancer with Dr. Paolo Bossi | OncoInfluencers

In this episode of OncoDaily, Dr. Paolo Bossi, Associate Professor of Oncology at Humanitas University,…

Nov 14, 2024, 00:05 | Blog

Stephen V Liu: Federico Cappuzzo on perioperative immunotherapy at VIII Thoracic Oncology Conference

Stephen V Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown…

Nov 12, 2024, 13:38 | Blog

Shabnam Eghbali on Metastatic Melanoma treated with IO therapy - Vanderbilt Hem/Onc

Vanderbilt Hem/Onc shared a post on X: "Dr. Shabnam Eghbali, PGY-2, Vanderbilt University Medical Center presented…

Nov 12, 2024, 13:35 | Blog

Petros Grivas: Highlighting Advancement in Immunotherapy and cutting-edge clinical trial innovations

Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…

Nov 12, 2024, 13:24 | Blog

AACR IO Conference on Discovery and Innovation in Cancer Immunology

AACR shared on LinkedIn: “Immunotherapy for cancer has come a long way, [but] it is not…

Nov 12, 2024, 11:04 | Blog

Angela Mastronuzzi: 54th SIN CONGRESS ROME 2024

Angela Mastronuzzi, Pediatric hematologist-oncologist and the Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital,…

Nov 10, 2024, 10:44 | Insight

Highlights from IKCSNA24: 20 Posts Not to Miss

The 2024 International Kidney Cancer Symposium: North America (IKCSNA24) held from November 7-9, 2024, at…

Nov 10, 2024, 00:33 | Insight

Marwan Fakih: Updated RIN results in MSS chemo-refractory non-liver metastatic colorectal cancer

Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on…

Nov 9, 2024, 20:08 | Blog

Dr. Sara Tolaney Discusses ESMO24 Insights on TroFuse-010 Trial in Advanced Breast Cancer

Dana-Farber’s Breast Oncology Center shared the following on X: “Dr. Sara Tolaney discussed ESMO24 Insights…

Nov 9, 2024, 20:04 | Blog

Toni Choueiri on the Flexibility of Therapies Beyond PD-1 Inhibitors

Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, shared…

Nov 9, 2024, 12:26 | Blog

Jonathan Lim: Join Fiona Thistlethwaite as a Clinical Fellow in Advanced Immunotherapy and Cell Therapy Team

Jonathan Lim, Clinical Senior Lecturer in Cancer Biology the University of Manchester, shared a post…

Nov 9, 2024, 12:04 | Insight

Celebrating 40 Years of TCR Discovery: A Gathering of Giants in T Cell Immunology

This year marks the 40th anniversary of the discovery of the T cell receptor (TCR),…

Nov 8, 2024, 12:37 | Positive

Jennifer Buell: Pioneering Leadership in Biotechnology

Dr. Jennifer Buell is a prominent figure in the biotechnology industry, currently serving as the…

Nov 7, 2024, 15:50 | Insight

Endometrial Cancer Advances - Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn: "For the past decade, new cases of endometrial…

Nov 7, 2024, 15:07 | Blog

Local control and toxicity after stereotactic radiotherapy in brain metastases patients

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, posted on X about recent…

Nov 5, 2024, 10:35 | Blog

Bristol Myers Squibb Reports Third Quarter Financial Results for 2024

Bristol Myers Squibb's Performance Reflects Continued Focus on Near-Term Execution and Building a Foundation for…

Nov 4, 2024, 15:55 | Insight

Yan Leyfman: An innovative approach to promote CAR T cell longevity and boost therapeutic efficacy

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn by Francisco…

Nov 4, 2024, 15:50 | Insight

Marwan Fakih: Updated RIN results in MSS chemo-refractory non-liver metastatic colorectal cancer

Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on…

Nov 3, 2024, 09:30 | Blog

Hidehito Horinouchi: Proud to be Mentoring Japan's Rising Star Masahiro Torasawa

Hidehito Horinouchi posted on X: "Proud to be Mentoring Japan's Rising Star Masahiro Torasawa Distinguished…

Nov 2, 2024, 17:53 | Blog

Last chance to register for ESMO Asia 2024 at discounted rates

ESMO - European Society for Medical Oncology, shared this post on LinkedIn: "Last chance to…